Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

The relationship of fibroblast growth factor 21 with cardiovascular outcome events in the Fenofibrate Intervention and Event Lowering in Diabetes study

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • بيانات النشر:
      Springer Verlag
    • الموضوع:
      2015
    • Collection:
      UNSW Sydney (The University of New South Wales): UNSWorks
    • نبذة مختصرة :
      Aims/hypothesis: Circulating fibroblast growth factor 21 (FGF21) levels are often elevated in obesity, dyslipidaemia, insulin resistance and type 2 diabetes. This study investigated the relationship of plasma FGF21 levels with cardiovascular events in patients with type 2 diabetes.
    • File Description:
      application/pdf
    • Relation:
      http://hdl.handle.net/1959.4/unsworks_13592; https://unsworks.unsw.edu.au/bitstreams/f7a37251-0453-4c4d-9a9f-2624281d90a4/download; https://doi.org/10.1007/s00125-014-3458-7
    • الرقم المعرف:
      10.1007/s00125-014-3458-7
    • Rights:
      open access ; https://purl.org/coar/access_right/c_abf2 ; CC-BY-NC-ND ; https://creativecommons.org/licenses/by-nc-nd/4.0/ ; free_to_read
    • الرقم المعرف:
      edsbas.D05AF1CC